Strides Pharma Science has received final USFDA approval to market laxative Polyethylene Glycol 3350 and Electrolytes for Oral Solution. The company has received this approval through its subsidiary Strides Pharma Global, Singapore. The drug will be marketed in the strengths of 236 grams/2.97 grams/6.74 grams/5.86 grams/22.74 grams/4 Liter.
The drug is a generic version of GoLYTELY of Braintree Laboratories and is likely to be manufactured in Bengaluru and will be marketed by Strides Pharma in the US market.
Company Profile : Strides Arcolab Ltd
Leave a Reply